Expression of Calretinin, Marker of Mesothelial Differentiation, in Pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall
Objective: Pancreatic ductal adenocarcinoma is one of the most common causes of "peritoneal carcinomatosis" and has an insidious growth pattern. Thus, it falls into the differential diagnosis of other peritoneal malignancies including malignant mesothelioma. Recently, we have encountered a...
Main Authors: | Gokce ASKAN, Olca BASTURK |
---|---|
Format: | Article |
Language: | English |
Published: |
Federation of Turkish Pathology Societies
2021-05-01
|
Series: | Türk Patoloji Dergisi |
Subjects: | |
Online Access: |
http://www.turkjpath.org/pdf.php3?id=1955
|
Similar Items
-
Using EMA and Calretinin on Cell Blocks for the Differentiation of Reactive Mesothelial Cells from Adenocarcinoma Cells in Pleural Effusions
by: Massood Hosseinzadeh, et al.
Published: (2022-07-01) -
Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
by: Gokce Askan, et al.
Published: (2021-04-01) -
Serum Calretinin as a Biomarker in Malignant Mesothelioma
by: Cita Zupanc, et al.
Published: (2021-10-01) -
Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma
by: Cita Zupanc, et al.
Published: (2023-12-01) -
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)